unknown
Stage
1
Investors
About
InCarda Therapeutics develops novel drug treatments aimed at safely and effectively restoring normal heart rhythm in patients with atrial fibrillation, focusing on therapies for both hospital and at-home use.
Explore InCarda Therapeutics Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.